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Laser fibre deterioration and loss of power output during
photo-selective 80-W potassium-titanyl-phosphate laser
vaporisation of the prostate
Abstract
BACKGROUND: The potassium-titanyl-phosphate (KTP) laser technique for photo-selective
vaporisation of the prostate (PVP) has been regularly improved over the last decade. Nonetheless,
decreasing efficiency of tissue vaporisation during the course of the operation and macroscopic
alterations of the laser fibre's tip are regularly observed and seem to affect the outcome of this
procedure. OBJECTIVE: To investigate the course of power output and to determine the type and extent
of fibre deterioration during PVP. DESIGN, SETTING, AND PARTICIPANTS: Forty laser fibres were
investigated during PVP in 35 consecutive patients with prostatic bladder outflow obstruction between
January 2007 and August 2007 in a university hospital. INTERVENTION: All patients underwent PVP
performed by three different surgeons using the 80-W KTP laser. MEASUREMENTS: Power output
was measured at the beginning and regularly throughout PVP and throughout in vitro vaporisation
without fibre-tissue contact. Microscopic documentation of the fibre tip was performed after the
procedure. RESULTS AND LIMITATIONS: Carbonisation and melting of the fibre tip was regularly
visible and appeared to be more pronounced as more energy was applied. Additionally, 90% of the
fibres showed a significant decrease of power output during PVP, resulting in an end-of-lifespan (ie,
275-kilojoule) median power output of 20% of the initial value. Final median power output after in vitro
vaporisation was 83% of the starting value. The extent of the structural and functional changes might
only be valid for the operative technique performed in this investigation. CONCLUSIONS: Fibre
deterioration caused significant reduction of power output during PVP. This finding is an explanation
for the often observed decreasing efficiency of tissue ablation and may also be responsible for some of
the typical drawbacks and complications of PVP. Hence, improvements in fibre quality are necessary to
advance the efficiency of this technique.
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1Abstract58
Background: 59
The potassium-titanyl-phosphate (KTP) laser technique for photo-selective vaporisation of 60
the prostate (PVP) has been regularly improved over the last decade. Nonetheless, decreasing61
efficiency of tissue vaporisation during the course of the operation and macroscopic 62
alterations of the laser fibre’s tip are regularly observed and seem to affect the outcome of 63
this procedure.64
Objective:65
To investigate the course of power output and to determine the type and extend of fibre 66
deterioration during PVP.67
Design, Setting and Participants:68
Forty laser fibres were investigated during PVP in 35 consecutive patients with prostatic 69
bladder outflow obstruction between January and August 2007 in a university hospital. 70
Intervention71
All patients underwent PVP performed by 3 different surgeons using the 80W KTP laser.72
Measurements73
Power output was measured at the beginning and regularly throughout PVP and throughout 74
in-vitro vaporisation without fibre-tissue contact. Microscopic documentation of the fibre tip 75
was performed after the procedure.76
Results and Limitations77
Carbonisation and melting of the fibre tip was regularly visible and appeared to be more 78
pronounced as more energy was applied. Additionally, 90% of the fibres showed a significant79
decrease of power output during PVP, resulting in an end of lifespan (i.e. 275kilojoule) 80
median power output of 20% of the initial value. Final median power output after in-vitro81
vaporisation was 83% of the starting value. The extent of the structural and functional 82
changes might only be valid for the operative technique performed in this investigation.83
2Conclusions84
Fibre deterioration caused significant reduction of power output during PVP. This finding is 85
an explanation for the often observed decreasing efficiency of tissue ablation and may86
furthermore be responsible for some of the typical draw-backs and complications of PVP. 87
Hence, improvements in fibre quality are necessary to advance the efficiency of this 88
technique.89
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3Introduction110
Photo-selective vaporisation of the prostate (PVP) using the potassium-titanyl-phosphate 111
(KTP) laser was introduced in the mid-1990’s to treat patients suffering from obstructive 112
symptoms caused by benign prostatic hyperplasia (BPH) [1]. Since then, substantial 113
modifications have been made to improve this technology ([2] for recent review).114
Several studies have shown that PVP is feasible and safe [3-5] but long-term results are still 115
lacking [6]. The combination of tissue ablation and simultaneous coagulation results in a 116
virtually bloodless operation without absorption of irrigation fluid [7]. These characteristics 117
of the KTP laser allow for the operation of patients with high prostate volume [8], of high-118
risk patients [9, 10] and of patients under ongoing anti-coagulation treatment [11, 12]. 119
Despite these promising results some disadvantages of PVP have also been described120
including a longer operation time compared to the conventional trans-urethral resection 121
(TURP) [13, 14]. Furthermore, the high costs of the disposable fibres are continually under 122
discussion [15, 16]. Typical complications commonly reported for PVP are prolonged123
dysuria, delayed haematuria, bladder neck strictures, urinary retention and infections [3, 17].124
One reason for some of the disadvantages of PVP might be the quality of the laser fibre. 125
Unlike the power generator, there have been no reports on any substantial improvements to126
this component. The vulnerability of the laser fibre often becomes apparent as visible127
alterations to its tip. Structural deterioration of the fibre might lead to scattering and impaired 128
laser energy deposition, resulting in reduced tissue vaporisation and increased coagulation129
[18]. This, in turn, might be responsible for the often observed decreasing efficiency of tissue 130
ablation especially during the last third of the fibre’s lifespan [19]. These alterations could 131
result in a longer operation time and in some of the typical complications after PVP.132
To the best of our knowledge, investigations concerning the loss of power output during PVP133
have, so far, not been performed. Therefore, we investigated a series of PVP with regard to 134
4the course of power output during treatment and associated structural changes of the laser 135
fibre.136
137
Material and Methods138
Between January and August 2007, 40 IQ™ Greenlight PV® bPH fibres (Laserscope®, San 139
Jose, USA) were investigated during a consecutive series of PVP in 35 patients suffering 140
from prostatic bladder outflow obstruction. Patient characteristics are summarised in Table 141
1a. PVP using the 80W Greenlight PV® Laser System (Laserscope®) is the standard operative 142
BPH treatment in our department. It was performed by two laser-experienced urologists 143
(surgeon 1 and 2) with 300 and 150 previous operations, respectively, and one novice144
(surgeon 3) without PVP-experience. 145
The power of the laser beam was measured after its emission from the fibre using the PS-146
V3104 power detector coupled to a TMP-300CE power monitor (both: Gentec-EO, Quebec, 147
CDN; Fig. 1). Power measurements were performed at the start and regularly after the 148
application of every 25 kilojoule (kJ) throughout the operation resulting in 12 measurements 149
if the maximum energy of 275kJ was applied. The operative procedure was performed 150
according to the technique described by Bachmann and colleagues [19]. The laser fibre was 151
introduced into the prostatic urethra via a 25 French laser cystoscope. An automated152
irrigation–suction pump system (Endo Fluid Management System® Urology, Future Medical 153
System S.A., USA) and sterile saline were used for continuous irrigation. The end-point of 154
the procedure was a wide open TURP-like cavity surrounded by capsular fibres. 155
After the application of every 25kJ the fibre was withdrawn from the cystoscope. Following 156
manual cleaning of the fibre tip with a damp gauze pad, the fibre was positioned for further157
measurements (Fig. 1). At the end of the operation microscopic photo documentation of the 158
fibre tip was performed.159
5A standardised set-up was designed to create consistent conditions for each measurement. (1)160
The measuring head was placed in a special, sterile covered box to guarantee a steady 161
distance between the fibre and the measuring field. (2) A 2ml syringe without its plunger was 162
placed in a fixed position on the box to act as guiding channel for the fibres (Fig. 1). (3) A163
pneumatic on/off-switch was constructed to standardise the laser release time for each series 164
of measurements (insert of Fig. 1). Via an infusion tube it was attached to the footswitch 165
adapter of the laser console. The laser was released for a defined time by pressing the red 166
button of the switch. (4) The energy supplied per measurement was checked on the monitor 167
of the laser console to verify a constant energy output for all measurements.168
Controls with only a base-line measurement prior to vaporisation and a terminal 169
measurement at the end of a regular PVP were performed to investigate the impact of the 170
measurement itself on the course of power output.171
Additionally, in-vitro vaporisation was performed with two fibres to investigate fibre 172
deterioration and the course of power output without any fibre-tissue contact. For this 173
purpose, a piece of beef serving to absorb the laser energy was positioned in a container filled 174
with isotonic saline. The fibre was placed at a distance of at least 5cm from the piece to avoid 175
any contact. Under constant irrigation the laser was activated to 275kJ and measurements 176
were performed as described above.177
Statistical analysis was performed using the Statistical Package for the Social Sciences, 178
version 12.0.1 (SPSS Inc, Chicago, USA). The values collected prior to vaporisation were 179
defined as the base-line output values for each individual fibre. In order to compare the 180
course of power output of different fibres, differences in base-line output were normalised by 181
defining the base-line value for each measurement series as 100%. Subsequent values were 182
calculated and expressed as a percentage of the base-line value. The medians and quartiles183
were calculated from these percentage values. The median power output values at the 184
different measuring points were compared using the Wilcoxon signed-rank test. The Kruskal-185
6Wallis H-test was used to compare the course of the median power output between the three186
surgeons. For both tests a p-value of less than 0.05 was considered to be statistically 187
significant.188
189
Results190
Intra-operative data are summarised in Table 1b. High prostate volume resulted in one patient 191
requiring the use of three laser fibres to achieve complete vaporisation and three patients 192
requiring two laser fibres. The remaining 31 operations were completed using a single fibre. 193
During the course of the operation, all fibres developed visible damage to the emission 194
window. Microscopic evaluation revealed that fibre deterioration was largely caused by 195
melting and/or carbonisation in the region of laser emission. These alterations increased 196
together with the total energy supplied. Mild damage to the tip (i.e. superficial deterioration 197
only without melting of the fibre material) was solely found in the non-contact fibres. Fibres 198
from PVP with less then 175kJ applied were found to have moderate damage (i.e. incipient 199
delineation of the emission window caused by melted fibre material). Severe damage (i.e. 200
extensive melting) appeared after the application of 200kJ (Fig. 2). 201
The base-line values obtained prior to vaporisation showed distinct inter-fibre variation. The 202
initial values of all 40 fibres ranged from 3.8W to 10.8W with a median value of 6.17W203
(Tab. 2). 204
Four fibres (10%) had a stable course without a reduction of power output during treatment. 205
For these fibres median base-line power output was 7.4W (range: 6.2-10.8W), median energy 206
applied 275kJ (range: 200-275kJ) and median prostate volume 70ml (range: 40-80ml). 207
The remaining 36 fibres (90%) showed a clear decrease of power output (Tab. 2 and Fig 3). 208
Initially, the median power output decreased at a constant rate with each measurement. A 209
statistically significant reduction was detectable after the application of 75kJ (Tab. 2). At this 210
point, the median power output dropped to 93% (77-103% inter-quartile range (IR)). The 211
7subsequent values demonstrated a continued moderate reduction. However, between 200kJ 212
and 225kJ a pronounced decline of the median power output from 72% to 55% (45-82% IR)213
was detected. At the end of the 275kJ-lifespan of the fibres, the median power output was214
20% (17-46% IR). 215
In 134 of the total of 403 measurements (33.3%), slight increases of power output were 216
detected compared to the preceding measurement. These elevated values were relatively low 217
in comparison to the overall fall of power output observed over the life-time of the fibre. 218
The median course of power output for each surgeon is displayed in Figure 4. Twelve fibres 219
were tested by surgeon 1 (83min median operation time, 1 fibre with stable power output), 19 220
by surgeon 2 (90min, 2 stable fibres) and 9 fibres by surgeon 3 (103min, 1 stable fibre). No 221
statistical difference was found between the courses of power output measured for the three 222
surgeons. Furthermore, total reduction of power output, median energy applied and final fibre 223
deterioration were comparable (data not shown).224
No significant differences between the final power output of fibres used for vaporisation of 225
prostate cancer and those used for vaporisation of BPH tissue were found (data not shown). 226
The initial median power output of the 2 fibres tested in-vitro was 6.4W followed by a 227
moderate reduction during vaporisation. After the application of 275kJ the median power 228
output was 5,52W (83% of the initial value) and mild damage of the fibre tip was detectable 229
(Fig 2). From the beginning, two scatter beams laterally to the main beam could be seen in 230
both of the fibres.231
For the control fibres with only a base-line and an end-point measurement, a decrease of 232
power output comparable to this of the 36 fibres was detected (data not shown).233
234
Discussion235
The numerous modifications of the KTP laser system introduced over the last decade indicate 236
the ongoing development and improvement of the technique. The component mostly 237
8improved was the laser generator. Relatively little attention has been concentrated on the role 238
of the laser fibre. 239
Fibre deterioration during PVP has been reported [19] and the high power of the laser beam240
has been identified as a specific risk factor for this [20]. This phenomenon has also been 241
identified in Nd:YAG lasers [21]. Using a similar measurement set-up, te Slaa and colleagues 242
found a major transmission loss during treatment with two different Nd:YAG fibres. A clear 243
correlation between the degree of fibre damage and the loss of power output could not be 244
detected [22]. In accordance with these findings, the present investigations also revealed a 245
distinct decrease of power output during PVP which resulted in a final median transmission 246
loss of 80%. In contrast to the findings of te Slaa and colleagues, the loss of power was 247
accompanied by substantial fibre deterioration. The extent of these structural and functional 248
changes might be specific for the operative technique performed.249
Only 10% of the fibres maintained a stable power output - a performance that should be 250
expected for all fibres. There is no evidence that prostate volume or experience of the 251
surgeon had a significant impact on the better performance of these fibres. The relatively 252
high base-line values rather suggest that it was a result of superior fibre quality.253
The distinct variances of the base-line power output values support the notion that there is a 254
significant difference in the quality of individual fibres. For example, initial scattering as was 255
observed during in-vitro vaporisation is likely to be due to poor fibre quality and, without 256
much doubt, results in reduced base-line power output. To some degree the variances might 257
have also been generated by the equipment used in the present investigation. Regardless of 258
the efforts to standardise the set-up, a certain measurement inaccuracy cannot be excluded.259
Dynamic changes of the emission window might be responsible for the elevated power 260
output values of single fibres during PVP. Melting may result in different configurations of261
the emission window, thus leading to dispersion of the laser beam. Particles that cause 262
scattering may disappear again during treatment resulting in reduced scattering and 263
9consequent re-improvements in power output. However, a certain degree of power output 264
elevation may also be a consequence of measurement inaccuracies. 265
The control fibres with only an initial and a final measurement demonstrate that repeated 266
fibre testing had no negative impact on the course of power output.267
Several recommendations have been proposed to prevent premature fibre degradation. 268
Sufficient irrigation over a clean fibre and the maintenance of the recommended fibre-tissue 269
distance are crucial to limit fibre destruction caused by reflected heat [2, 20]. We strictly 270
followed these recommendations. The fibre was cleaned prior to each measurement to 271
prevent accumulation of heat-reflecting adherent tissue. Adequate irrigation was warranted 272
by the use of the irrigation–suction pump system. 273
Fibre-tissue distance is regarded as the main cause for heat reflection [20]. The results of the 274
in-vitro measurements of the present investigation support this assumption. Non-contact 275
vaporisation resulted in a significantly lower reduction of power output compared to the 276
regular PVP. However, controlling fibre-tissue distance in vivo might be difficult for several 277
reasons. The recommended optimal distance of 0.5-1mm may be hard to maintain, especially 278
in a tight prostatic urethra [23]. Moreover, it is demanding to sustain this distance while 279
performing the recommended sweeping vaporisation technique. Being over-cautious and 280
increasing the distance would certainly result in reduced reflective heat, but also bear the risk 281
of insufficient tissue vaporisation and increased coagulation [24]. Visibility is often impaired 282
by the jitter of the laser beam and vigorous air bubble formation caused by tissue 283
vaporisation. Another important point in this context is the frayed surface of the prostatic 284
cavity which is formed by residual ‘coral-like’ or ‘cotton wool’ stromal fibres [17, 25]. With285
increasing tissue vaporisation these fibres can extend up to several millimetres into the 286
prostatic cavity. The fibre has to be moved through these ‘corals’ to vaporise the deeper parts 287
of the prostate. Hence, a contact-free vaporisation is scarcely possible.288
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The differences between the courses of power output measured for the three surgeons were 289
not statistically significant. Thus, surgeon’s experience seems to have no major impact on the 290
reduction of power output.291
From the clinical point of view our findings are of considerable relevance because 292
malfunction of the laser fibre might lead to serious safety problems, particularly when high-293
risk patients are operated. The underlying reasons are closely connected to the biophysical 294
properties of the KTP laser. Lower power output leads to insufficient heating of the tissue.295
This results in a less vigorous vaporisation and unwanted tissue coagulation [18, 26]. The 296
longer the application of low power densities of laser energy, the deeper the levels of 297
coagulation will be. Finally, depending on the depth of the coagulation zone, the laser with a298
penetration depth of 1-2 mm is no longer able to reach the deeper vascularised regions. The  299
resulting extensive coagulation zone [18, 27] mimics the draw-backs of the Nd:YAG laser300
operation. Residual necrotic tissue is known to cause side effects such as dysuria, urinary 301
retention and infections which are responsible for prolonged post-operative patient 302
discomfort [28, 29].303
Deterioration of the emission window not only leads to a higher likelihood of coagulation but 304
also to scattering with uncontrolled emission of the laser beam. This can result in unwanted 305
destruction of non-targeted tissue. Since scattering is more pronounced towards the end of the 306
procedure when vaporisation takes place in the region of the external sphincter, a change of 307
the operative technique might be advisable. The development of several operative techniques 308
in the recent past reflects the search for ways to reduce fibre deterioration and to improve the 309
safety and efficiency of PVP [23]. Nonetheless, the prerequisite for a perfect in vivo 310
performance is an adequate durability of the laser fibre. This, however, requires substantial 311
quality improvements of the fibre (e.g. increased heat resistance of the fibre tip).312
Meanwhile, the more powerful 120W-Greenlight-HPS® Laser System has been launched. 313
Not only higher power but also changes in beam characteristics and improved fibre quality 314
11
have been reported [20]. The ability of these improved fibres to withstand the higher power 315
of the new laser and the impact of structural and functional changes on the clinical outcome316
are currently under investigation in our institution.317
318
Conclusions319
We found a significant decrease of power output associated with substantial deterioration of 320
the laser fibre’s emission window during PVP. These alterations appear to be due to sub-321
optimal properties of the laser fibre itself and might be responsible for some of the 322
characteristic draw-backs of PVP, such as long operating times and typical post-operative 323
complications. It may be anticipated that improved fibre quality could result in a better and 324
more consistent patient outcome. 325
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Table 1: Pre- and intra-operative parameters of 35 patients 468
a) Pre-operative
Number of patients 35
Age (yr) 71 (47-85)
Prostate volume (ml) 50 (25-155)
BPH 32 (91.4%)
Prostate cancer 3 (8.6%)
PSA (ng/ml) 4,93 (0.48-178.4)
Residual volume (ml) 80 (0-1400)
Indwelling catheter 7 (20%)
Anticoagulation 
(CD / PAI)
14 (40%)
(7 / 7)
b) Intra-operative
Number of fibres 40
Operation time (min) 90 (60-205)
Energy applied per fibre (kJ) 237 (125-275)
Energy applied per patient (kJ) 250 (125-550)
Irrigation volume (l) 18 (9-27)
Data are presented as median (range) or number (percent); 
BPH = benign prostatic hyperplasia, PSA = prostate 
specific antigen, CD = coumarin derivates, PAI = platelet 
aggregation inhibitors
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
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Table 2: Total number of fibres, median power output and range after the application of n kJ. 495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
Applied energy (kJ) 0 25 50 75 100 125 150 175 200 225 250 275
Number of fibres 36 36 36 36 36 36 35 30 29 25 17 11
Median power output (W) 6.07 6.35 5.95 5.93 5.48 5.61 5.72 4.80 4.71 4.21 2.47 1.30
Range of power output (W) 3.8 - 10.8 3.9 - 9.7 3.5 - 9.6 3.0 - 9.2 2.5 - 12.2 0.5 - 9.4 0.5 - 8.8 1.1 - 8.4 0.9 - 8.14 0.7 - 8.3 0.5 - 6.24 0.4 - 6.3
p-value 0.16 0.051 0.02* 0.001* 0.004* 0.013* < 0.001* < 0.001* < 0.001* < 0.001* 0.003*
* indicates a significant decrease of the median power output (p<0,05)
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Figure legends516
517
Fig. 1: Set-up for the measurement showing the on-off-switch (asterisk) and the power 518
monitor (white arrow). The power detector (black arrow) is placed in a special box and a 519
syringe (black arrowhead) on top of it guides the laser fibre. 520
Insert of Fig. 1: Detailed view of the custom built pneumatic switch. A syringe (white 521
arrowhead) was used to generate the air pressure needed to release the laser.522
523
Fig. 2: Substantial deterioration of the fibre tip in the region of laser emission caused by 524
melting and carbonisation. The more energy had been supplied, the more pronounced the 525
damage of the fibre tip was. A clean, virgin fibre can be seen on the left side and a fibre after 526
in-vitro vaporisation performed without tissue contact on the right side. (Scale bar: 2 mm; 527
NC = non-contact)528
529
Fig. 3: Medians of power output and interquartile range of all 36 measurement series.530
531
Fig. 4: Courses of median power output of the three different surgeons (surgeon 1: 300 532
previous operations, surgeon 2: 150 previous operations and surgeon 3 without KTP laser 533
experience).534




